In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic Navigation

Division of Medtronic PLC

Latest From Medtronic Navigation

Alphatec: Betting On the Aging Spine

Once a small manufacturer of custom products, Alphatec was acquired by HealthpointCapital in 2005 with the goal of turning the company into a major player in spine. Alphatec's strategy has been to target important new technology areas, such as minimally invasive surgery and biologics, with a special focus on elderly patients and the specific problems they face. A merger with Scient'x brought Alphatec additional products for its pipeline and, more importantly, a commercial infrastructure in Europe. Like other spine companies, Alphatec faces a host of issues, including pricing pressures, pushback on covered procedures by payors, and uncertainty at the FDA. Adding to the challenge for Alphatec: its role as a publicly traded company. A company whose product development efforts more closely resemble that of a venture-backed start-up went public, partly to raise the capital to fuel strong growth. But like any publicly traded company, Alphatec's stock has been on a roller coaster since its IPO in 2006. Last spring, the company missed its numbers and the stock took a huge hit. Critics charge that the company has lagged in product development; while company officials insist that the pipeline is rich, believing that the strong pipeline will push Alphatec into the front ranks of the industry.
Medical Device Business Strategies

Pathfinder Therapeutics Inc.

Market growth in image-guided surgery will come, in part, from new technologies that can guide surgeons in soft tissue. Pathfinder Therapeutics Inc. thinks its IGS platform, built on 15 years of academic R&D by pioneers in IGS, fits the bill. The first application is for the large, unmet need in treating liver cancer. Currently, just 20% of patients are eligible for open liver surgery, the current gold standard treatment.
Medical Device Platform Technologies

Intraoperative Imaging for the OR of Today

Intraoperative imaging using MRI brings real-time imaging into the neurosurgical suite, complementing other methods of helping neurosurgeons visualize their operating fields. Neurosurgical interest seems high, but with the technology new and extremely expensive, adoption rates are at a crawl. Two big players, Siemens and GE, are in the market. Now, Odin Medical, an Israeli start-up, is offering a lower cost, but less powerful system that it says is more practical and adequate for neurosurgeon's needs. A new deal with Medtronic's Surgical Navigation Technologies division should help drive sales.
Medical Device Strategy
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Cancer
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Medtronic Surgical Navigation Technologies
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Medtronic PLC
  • Senior Management
  • Andrew Weiss, Pres.
  • Contact Info
  • Medtronic Navigation
    Phone: (720) 890-3200
    826 Coal Creek Circle
    Louisville, CO 80027